Biovian is a market leader within in contract manufacturing and development of biopharmaceuticals
Founded in 2003 and based in Turku, Finland, Biovian offers outsourcing services in process development and contract manufacturing for small and medium size biotechnology firms and has deep industry expertise across different key biological processes.
Biovian has around 70 employees, specialized in different key stages of the drug development lifecycle. With main operations in Europe, the US and South Korea, the company benefits from a strong Biotech pipeline, fueled by new biologic products progressively replacing traditional pharma.
EQT Credit provided a Unitranche financing to support Keensight and ERES’ acquisition of Biovian, which is expected to continue to benefit from the attractive growth characteristics of the biopharma market.